Compare

GHRP-2 vs Ovagen

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

Last reviewed . By the PeptIQ team.

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.

GHRP-2

1236 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 60% · Mixed 32% · Unfavorable overall 8%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
159
Focus
165
Sleep quality
31
Lean mass
126
Joint comfort
161

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
75
Nausea
64
Water retention
176
Appetite loss
122
Injection site reaction
160

Self-reported dose per injection

Median bucket: 100–200 mcg · Most common: 100–200 mcg

Reports span 25–600 mcg

25–50
2
50–100
13
100–200
22
200–400
11
400–600
2

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing40stacking18side effects26ghrp-219

How repeat users are trending

Among repeat reporters, 55% said they felt similar to their last entry, 34% more positive, and 20% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 29 days · Based on 272 repeat reporters

Ovagen

838 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 52% · Mixed 30% · Unfavorable overall 18%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Mood
-167
Focus
-101
Sleep quality
-138
Lean mass
-30
Joint comfort
-16

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
-71
Nausea
-21
Water retention
7
Appetite loss
-34
Injection site reaction
-17

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.4–0.6 mg

Reports span 0.05–2 mg

0.05–0.1 mg
1
0.1–0.2 mg
4
0.2–0.4 mg
14
0.4–0.6 mg
22
0.6–1 mg
11
1–2 mg
7

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

Common discussion topics

timing42stacking40side effects18ovagen21

How repeat users are trending

Among repeat reporters, 62% said they felt similar to their last entry, 44% more positive, and 12% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 30 days · Based on 184 repeat reporters

Sources (4)

Published sources linked on the GHRP-2 and Ovagen wiki pages.

  1. PubMed

    Growth hormone-releasing peptides: clinical applications

    Ghigo E, Arvat E, Camanni F. Endocrine. 2008

    Source
    Wiki study page →